Enlarge / A mouse embryo with the nervous system highlighted in blue.
Embryos start out as a single cell and have to go from there to a complicated array of multiple tissues. For organisms like insects or frogs, that process is pretty easy to study, since development takes place in an egg that's deposited into the environment shortly after fertilization. But for mammals, where all of development takes place inside the reproductive tract, understanding the earliest stages of development is a serious challenge. Performing any experiments on a developing embryo is extremely difficult and effectively impossible at some stages.
This week, however, progress has been made with both human and mouse embryos. On the human side, researchers have used induced stem cells to create embryo-like bodies that perform the first key step in development, catching them up to where mouse research has been for decades. On the mouse side, however, a research team has gotten mouse embryos to go for nearly a week outside the uterus. While that opens up a world of experiments that hadn't previously been possible, the requirements for getting it to work means that it's unlikely to be widely adopted.
The mouse work was somewhat more interesting technically, so we'll get to that first. One of the most critical steps in the development of vertebrates is called gastrulation. The process takes some cells that have been set aside during the early embryo and converts them into three critical layers that go on to form the embryo: the skin and nerves, the lining of the gut, and everything else.
Gastrulation takes place between six and seven days after fertilization, and a lot of key developmental events take place shortly afterward: the formation of nerve cells and their organization, the development of the ordered structures that form the vertebrae, and more. But, given the size of the embryo at this time and its location in the uterus, the process of gastrulation is essentially invisible.
A large team based in Israel decided to figure out how to change that. It first started with embryos that had already passed the critical stages of gastrulation, and figured out how to get them to survive. It was... not simple. To start with, the embryos had to be incubated in a bottle that constantly rotated in order to ensure all the nutrients and oxygen around the embryo were thoroughly mixed, instead of allowing the embryo's energy demands to create a local "dead zone" around it.
The oxygen levels had to be controlled through a custom in-house gas supply system that ramped up the pressure over time in order to force more oxygen into solution. And fresh glucose had to be regularly infused into the liquid medium as well.
About that liquid medium. About a quarter of it was something you could buy out of a standard biotech supply catalog. The rest was substantially harder to come by. Half of it was serum obtained from rat blood. And a quarter was serum obtained from human umbilical cord blood. Neither of these is particularly easy to come by. They tested, and you really do need the human blood; rat blood alone wasn't nearly as good. (How often do I get to write a sentence like that?)
In any case, this was enough to get the embryos through four days of development. This took them from three layers of unspecialized cells to a place where the spinal cord had started to form and limbs started budding off the side of the embryo. That, in development terms, includes a whole lot of important events that we are very interested in studying.
But, by this point, the embryo's growing circulatory system should have integrated with the placenta, ensuring the entire embryo was well supplied with nutrients and oxygen. The embryos died in a way that suggested an oxygen supply was probably lacking.
While an accomplishment, this all takes place after gastrulation has happened. So, the researchers backed up a bit further, isolating embryos between four and five days after fertilization. The same medium worked, but here, the embryos didn't need to be in a rotating bottle in order to survive. The two incubations could be combined, essentially taking the embryos through an entire week of development outside the uterus.
In addition, the team showed that it could perform a variety of manipulations on the embryos during this time in culture. This included inserting DNA into their cells (using either a virus or electrical currents), or adding in stem cells to see how they develop. So, for anyone willing to get enough rat and umbilical blood to make this all work, there's a lot of developmental biology research that can now be done on mouse embryos.
The one thing that's not obviously accessible through this work is the earliest developmental process, in which a cavity opens up in the uniform-looking ball of cells formed by the first cell divisions of the fertilized egg. This creates the first somewhat specialized populations of cells in the embryo (both the ones on the exterior, and a patch of cells inside the cavity). The resulting structure is called a blastocyst.
For mice, we've been able to take a fertilized egg and grow it into a blastocyst in culture for years. But this hasn't been done with human cells. And, to a degree, it still hasn't. Instead, two different labs started with stem cells, either embryonic stem cells or stem cells induced from adult tissues. In contrast to the mouse work, getting the embryo to go this far could be done with off-the-shelf ingredients in the media that the cells were grown in.
This opens up the earliest stages of human development to study. But, while formation of the blastocyst is interesting, a lot more goes on at later stages of development. And here, ethical concerns are likely to limit how far we're going to be willing to take human tissue in culture.
The interesting thing here is that we can already get mouse embryos to develop into blastocysts, and now we can take blastocysts well on their way through development. So it seems likely that we can probably connect the two processes with a bit of work. That would be enough to get from fertilization through about two-thirds of the way to birth. That's pretty impressive.
But by this point, the embryo is getting very three-dimensional, and getting all the cells supplied with oxygen and nutrients really requires a functional blood supply plugged into a source for all the embryo's needs. And it's not clear how exactly we could substitute for the placenta, which hosts a very elaborate and specialized interchange between the fetal and maternal blood streams. In practical terms, though, these results mean a whole range of experiments are now possible in miceprovided you're willing to bleed enough rats.
Nature, 2021. DOI: 10.1038/s41586-021-03416-3, 10.1038/s41586-021-03372-y, 10.1038/s41586-021-03356-y (About DOIs).
Continue reading here:
- ThermoGenesis : The History of Cell and Gene Therapy - Marketscreener.com - April 14th, 2021
- Cord Blood Stem Cells Market 2021 Overview, Opportunities, In-Depth Analysis by 2027 : Becton, Dickinson and Company, DomaniCell, LLC, Future Health... - April 14th, 2021
- Umbilical Cord Blood (UCB) Stem Cell Market Booming CAGR +10% by 2028|| Osiris Therapeutics, Athersys, Opexa Therapeutics, NeoStem, Mesoblast Limited,... - April 14th, 2021
- Cord Blood Stem Cells Market 2021 Is Rapidly Increasing Worldwide in Near Future | Top Companies Analysis- Advanced Cell Technology, California Stem... - April 14th, 2021
- Cidara Therapeutics to Present at the 20th Annual Needham Virtual Healthcare Conference - April 8th, 2021
- Vincerx Pharma To Host Key Opinion Leader Webinar on Bioconjugation and CDK9 Inhibitors for the Treatment of Hematologic and Solid Tumors - April 8th, 2021
- Cabaletta Bio to Present at the 20th Annual Needham Healthcare Conference - April 8th, 2021
- Arch Oncology Appoints Laurence Blumberg, M.D. President and CEO - April 8th, 2021
- X4 Pharmaceuticals to Present at the 20th Annual Needham Virtual Healthcare Conference - April 8th, 2021
- Immutep Announces European Patent Grant For LAG525 Antibody In Combination Therapy - April 8th, 2021
- Cannalogue Expands Compassionate Care Program to Provide Lowest Medical Cannabis Price in Canada - April 8th, 2021
- Allena Pharmaceuticals Appoints Mark J. Fitzpatrick to its Board of Directors - April 8th, 2021
- Fortress Biotech to Participate in the 20th Annual Needham Virtual Healthcare Conference - April 8th, 2021
- Chinook Therapeutics Announces First Patient Dosed in Phase 2 AFFINITY Basket Study of Atrasentan in Proteinuric Glomerular Diseases - April 8th, 2021
- Rhythm Pharmaceuticals to Present at 20th Annual Needham Virtual Healthcare Conference - April 8th, 2021
- NKGen Biotech Announces Appointment of Philip Moody as Chief Financial Officer - April 8th, 2021
- CorMedix Inc. to Present at the 20th Annual Needham Virtual Healthcare Conference - April 8th, 2021
- Innovation Pharma Announces Brilacidin Abstract Accepted for Oral Presentation at the American Society for Virology’s Annual Meeting - April 8th, 2021
- AIM ImmunoTech Announces Positive Safety Data in First Cohort of Phase 1 Clinical Study Investigating Intranasal Administration of Ampligen as a... - April 8th, 2021
- Cullinan Oncology, Inc. to Participate in the 20th Annual Needham Virtual Healthcare Conference - April 8th, 2021
- Cord Blood Stem Cells Market 2021 Is Booming Across the Globe by Share, Size, Growth, Segments and Forecast to 2027 | Top Players Analysis- Advanced... - April 6th, 2021
- Cord Blood Stem Cells Market 2021 Will Reflect Significant Growth in Future with Size, Share, Growth, and Key Companies Analysis- Advanced Cell... - April 6th, 2021
- 25 Children with Autism Treated with Cord Blood: How Efficient is the Treatment? - Science Times - April 6th, 2021
- Latest Trending Report on Cord Blood Stem Cells Market by Advanced Cell Technology, California Stem Cell, Cytori Therapeutics, Mesoblast Limited,... - April 3rd, 2021
- The Governments Watchful Eye on Fraud Stemming from Stem Cell Therapy - JD Supra - April 3rd, 2021
- Hematopoietic Stem Cells Transplantation Market 2021 Analysis, Growth By Top Companies with Forecast 2025 : CBR Systems, ThermoGenesis, China Cord... - April 1st, 2021
- Why Hematopoietic Stem Cells Transplantation Market will be in Trend in Coming Period? Top Key Players- CBR Systems, China Cord Blood Corporation,... - April 1st, 2021
- Global Cell Isolation Market Sales Scenario of to Stay Positive Through 2026 KSU | The Sentinel Newspaper - KSU | The Sentinel Newspaper - April 1st, 2021
- Hematopoietic Stem Cell Transplantation (HSCT) Market 2021 Is Booming Across the Globe by Share, Size, Growth, Segments and Forecast to 2027 | Top... - April 1st, 2021
- Global Autologous Stem Cell Based Therapies Market Industry Size, Future Trends, Development Strategy, Growth Factors, Top Players, Historical... - March 30th, 2021
- Hematopoietic Stem Cells HSCs Market 2021 Will Reflect Significant Growth in Future with Size, Share, Growth, and Key Companies Analysis- Kite Pharma... - March 30th, 2021
- Vita 34 continues to grow in 2020 in core markets after good year-end business - PharmiWeb.com - March 30th, 2021
- Biobanking Market | 2021 Global Industry Analysis by Covid-19 Impact On Healthcare Sector, Business with Forecast to 2027 The Bisouv Network - The... - March 30th, 2021
- Cord Blood Stem Cells Market to Witness Strong Growth Over 2021-2027 | Key Manufacturers Overview- Advanced Cell Technology, California Stem Cell,... - March 26th, 2021
- Stem Cell Assay Market Study Top Key Players, Application, Growth Analysis And Forecasts To 2016 2024 FLA News - FLA News - March 26th, 2021
- Inner Wheel Blayney held a cord blood fundraising event in the Community Centre - Blayney Chronicle - March 26th, 2021
- Research on Stem Cells Cryopreservation Equipments Market Key Data Points Necessary for Effective Strategies | Chart, Worthington Industries, Cesca... - March 26th, 2021
- Stem Cells Cryopreservation Equipments Market : Trends, Growth, Regions, Types and Key Developments, Applications By 2026 | Chart, Worthington... - March 26th, 2021
- Stem Cell Therapy Market- What Are The Main Factors That Contributing Towards Industry Growth? The Bisouv Network - The Bisouv Network - March 24th, 2021
- Stem cells from umbilical cords might be the answer for severely ill COVID patients: Canadian researchers - National Post - March 24th, 2021
- Global Stem Cell Banking Market Projected to Gain Significant Value by 2021-2025 The Bisouv Network - The Bisouv Network - March 24th, 2021
- Hematopoietic Stem Cell Transplantation Market to See Major Growth by 2026 | Gilead Sciences, Cesca Therapeutics, R&D Systems Investments Revolution... - March 22nd, 2021
- Umbilical Cord Blood Stem Cells - March 22nd, 2021
- Cell Transplant Market 2021 Will Reflect Significant Growth in Future with Size, Share, Growth, and Key Companies Analysis- Regen Biopharma, Global... - March 22nd, 2021
- [Full text] Early Detection of Negative Smoking Impacts: Vascular Adaptation Devia | VHRM - Dove Medical Press - March 22nd, 2021
- Global Hematopoietic Stem Cell Transplantation (HSCT) Market Size by Top Key Players are including in this report: Regen Biopharma Inc, China Cord... - March 18th, 2021
- Stem Cell Therapy Market expected to reach USD 16.51 Billion by 2025 with the CAGR of 8.5% FLA News - FLA News - March 18th, 2021
- Research on Stem Cells Cryopreservation Equipments Market 2021 : By Growing Rate, Type, Applications, Geographical Regions, and Forecast to 2026 KSU... - March 18th, 2021
- Father, daughter honored for their work supporting nonprofit - dayton.com - March 18th, 2021
- Stem Cell Therapy Market Size | Growth, Opportunities, Trends And Forecast To 2027 Cabell Standard - Cabell Standard - March 18th, 2021
- Global Cell Transplant Market 2020 Overview of Vital Industry Drivers | Top Players Regen Biopharma , Global Cord Blood Corporation , Escape... - March 18th, 2021
- This is not science fiction. Israeli researchers have grown an embryo outside the womb - Haaretz - March 18th, 2021
- Global Stem Cells Cryopreservation Equipments Industry Market 2021 Overview, Opportunities, In-Depth Analysis by 2027:Sichuan mountain vertical, Cesca... - March 18th, 2021
- One step closer to treating spinal cord injury with our own stem cells - Speaking of Research - March 17th, 2021
- Global Stem Cell Therapy Market to Reach $242.3 Million by 2027 - GlobeNewswire - March 17th, 2021
- Global Cord Stem Cell Banking Market Is Expected To Bring In USD 13.8 Billion By 2026 - PharmiWeb.com - March 17th, 2021
- Global Stem Cells Banking Market 2026 : Analyse the Industry Developments and Investment Decisions of Esperite, Neostem, Smart Cells International ... - March 17th, 2021
- Gamida Cell Presents Efficacy and Safety Results of Phase 3 Study of Omidubicel in Patients with Hematologic Malignancies at the 47th Annual Meeting... - March 17th, 2021
- Research Antibodies Market is Driven by Increasing Incidence of Chronic Diseases and Life-threatening Diseases KSU | The Sentinel Newspaper - KSU |... - March 17th, 2021
- Hematopoietic Stem Cell Transplantation (HSCT) Market Analysis, Growth, Emerging Trends, Opportunity and Forecast To 2027 FLA News - FLA News - March 17th, 2021
- Placental Stem Cell Therapy Market: Regenerative Ability to Develop into Other Types of Cells to Drive Global Market - BioSpace - March 13th, 2021
- Global Stem Cell Banking Market Comprehensive Study Explores Huge Growth Near in The Future||SMART CELLS PLUS, LifeCell International, Global Cord... - March 13th, 2021
- The Insight Partners's Detailed Report on Stem Cell Umbilical Cord Blood (UCB) Market Offers Projections of Potential Impact of Corona Virus Outbreak ... - March 11th, 2021
- Affimed Announces Presentations at the AACR Annual Meeting 2021 - GlobeNewswire - March 11th, 2021
- Cord Blood Stem Cells Market Trends 2021-2026 with Opportunities, Challenges and Companies' Profile Advanced Cell Technology, California Stem Cell,... - March 9th, 2021
- Stem Cell Therapy Useful In The Treatment Of A Range Of Diseases - Nerd's Magazine - March 9th, 2021
- Cord Blood Stem Cells: An Overview | The Center for ... - March 7th, 2021
- Stem cells can give new life to ovaries and potentially restore fertility - Salon - March 7th, 2021
- Chromosomal translocation t(11;14) and p53 deletion induced by the CRISPR/Cas9 system in normal B cell-derived iPS cells - DocWire News - March 7th, 2021
- Hematopoietic Stem Cell Transplantation (HSCT) Market 2021 Will Reflect Significant Growth in Future with Size, Share, Growth, and Key Companies... - March 5th, 2021
- Black people are three times less likely to find a bone marrow donor than white people - WLNS - March 5th, 2021
- Therapeutic Solutions International Spin-off Campbell Neurosciences Announces Umbilical Cord Derived Monocyte Immunotherapy Candidate for Suicide... - March 5th, 2021
- Global Hematopoietic Stem Cells Transplantation Market 2020 In-depth study, Size, Trends, Emerging Growth Factors and Regional Forecast to 2025 The... - March 5th, 2021
- Why Global Cord Blood Corporation Stock Is Jumping Today - Motley Fool - March 3rd, 2021
- NYCU shares lung therapy data with firms - - March 3rd, 2021
- Covid-19 Impact on Global Stem Cells Cryopreservation Equipments Market (2020-2025) | Potential growth, attractive valuation make it is a long-term... - March 3rd, 2021
- Autologous Stem Cell Based Therapies Market Analysis By Industry Value, Size, Top Companies And Growth Forecast To 2025 KSU | The Sentinel Newspaper... - March 3rd, 2021
- Global Cord Blood Corp.: Subscriber Growth Continues With 23% EPS CAGR And 25% FCF Yield - Seeking Alpha - March 3rd, 2021
- Overcoming chemotherapy resistance in leukemia with a diarrhea drug from Merck - FierceBiotech - March 3rd, 2021
- Global Cord Blood Banking Services Market 2021 | Growing Rapidly with Significant CAGR, Leading Players, Innovative Trends and Expected Revenue by... - February 21st, 2021